1. Home
  2. TVTX vs DNN Comparison

TVTX vs DNN Comparison

Compare TVTX & DNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • DNN
  • Stock Information
  • Founded
  • TVTX 2008
  • DNN 1936
  • Country
  • TVTX United States
  • DNN Canada
  • Employees
  • TVTX N/A
  • DNN 64
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • DNN Other Metals and Minerals
  • Sector
  • TVTX Health Care
  • DNN Basic Materials
  • Exchange
  • TVTX Nasdaq
  • DNN Nasdaq
  • Market Cap
  • TVTX 1.3B
  • DNN 1.2B
  • IPO Year
  • TVTX N/A
  • DNN 1997
  • Fundamental
  • Price
  • TVTX $14.92
  • DNN $1.38
  • Analyst Decision
  • TVTX Strong Buy
  • DNN Strong Buy
  • Analyst Count
  • TVTX 13
  • DNN 2
  • Target Price
  • TVTX $33.75
  • DNN $3.00
  • AVG Volume (30 Days)
  • TVTX 2.0M
  • DNN 73.0M
  • Earning Date
  • TVTX 05-05-2025
  • DNN 05-07-2025
  • Dividend Yield
  • TVTX N/A
  • DNN N/A
  • EPS Growth
  • TVTX N/A
  • DNN N/A
  • EPS
  • TVTX N/A
  • DNN N/A
  • Revenue
  • TVTX $233,175,000.00
  • DNN $2,796,002.00
  • Revenue This Year
  • TVTX $68.31
  • DNN $252.42
  • Revenue Next Year
  • TVTX $55.65
  • DNN N/A
  • P/E Ratio
  • TVTX N/A
  • DNN N/A
  • Revenue Growth
  • TVTX 60.55
  • DNN 116.87
  • 52 Week Low
  • TVTX $5.12
  • DNN $1.08
  • 52 Week High
  • TVTX $25.29
  • DNN $2.47
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 37.07
  • DNN 52.25
  • Support Level
  • TVTX $14.13
  • DNN $1.08
  • Resistance Level
  • TVTX $15.23
  • DNN $1.35
  • Average True Range (ATR)
  • TVTX 1.31
  • DNN 0.09
  • MACD
  • TVTX -0.10
  • DNN 0.02
  • Stochastic Oscillator
  • TVTX 31.70
  • DNN 96.77

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About DNN Denison Mines Corp (Canada)

Denison Mines Corp is a uranium exploration and development company with interests focused in the Athabasca Basin region of northern Saskatchewan, Canada. The company has an effective 95% interest in its flagship Wheeler River Uranium Project, which is the largest undeveloped uranium project in the infrastructure-rich eastern portion of the Athabasca Basin region of northern Saskatchewan. The company is also engaged in mine decommissioning and environmental services through its Closed Mines group, which manages its Elliot Lake reclamation projects and provides third-party post-closure mine care and maintenance services.

Share on Social Networks: